↓ Skip to main content

Phase 1/2 study of epacadostat in combination with ipilimumab in patients with unresectable or metastatic melanoma

Overview of attention for article published in Journal for Immunotherapy of Cancer, March 2019
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (59th percentile)

Mentioned by

twitter
7 X users
facebook
1 Facebook page

Citations

dimensions_citation
65 Dimensions

Readers on

mendeley
87 Mendeley